As temperatures start to dip, a pediatrician shares her best advice for helping support children's immune systems.
From a promising alternative for the flu shot to hope for a "universal" vaccine, we take a look at how scientists at Johnson & Johnson are exploring novel ideas for preventing and treating the flu.
The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world's second largest outbreak of the disease.
Seven weeks. 19 students. One incredible experience. We're talking about the inaugural Girls Who Code Summer Immersion Program hosted at the company's Raritan location—and we captured it all on video. Watch as two high schoolers take us behind the scenes.
By the time she was in her 20s, Marisa Troy had endured numerous operations for ulcerative colitis. And when he became a new dad, Frank Garufi's life changed in ways he couldn't have imagined when his son was diagnosed with Crohn's disease. Then they found each other.
It's a common skincare dilemma: You're over the acne stage and wrinkles aren't yet a concern, but you're starting to notice dark spots, fine lines and dull skin. This new line can help address all of it—thanks to the team of millennial scientists behind it.
-
What You're Talking About
-
Fact
18%. That’s the five-year lung cancer survival rate. But a new study suggests that Johnson & Johnson may be one step closer to helping improve that figure.
Recent Johnson & Johnson Initiatives in the Spotlight
Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
